In the well-known instance of using HER2-targeted liposomes to deliver chemotherapeutic medicines for the treatment of breast cancer, trastuzumab coupled to the liposomal surface enhanced drug delivery and clinical results [267]. The gene discussed is ERBB2; the disease is breast carcinoma.